Afficher la notice abrégée

dc.contributor.authorRivas García, Francisco
dc.contributor.authorGiménez Martínez, Rafael Jesús 
dc.contributor.authorHuertas Camarasa, Felipe José
dc.contributor.authorMarch Cerdá, Joan Carles
dc.contributor.authorLloris Messeguer, Fuensanta
dc.contributor.authorLópez-Viota Gallardo, Margarita 
dc.date.accessioned2024-02-09T10:47:58Z
dc.date.available2024-02-09T10:47:58Z
dc.date.issued2023-12-30
dc.identifier.citationPharmaceuticals 2024, 17, 65es_ES
dc.identifier.urihttps://hdl.handle.net/10481/88844
dc.description.abstract“End of life” is a stage defined by the existence of an irreversible prognosis that ends with a person’s death. One of the aspects of interest regarding end of life focuses on parenteral nutrition, which is usually administered in order to avoid malnutrition and associated complications. However, parenteral nutrition can be adapted to specific circumstances and evolve in its functionality through supplementation with certain nutrients that can have a beneficial effect. This narrative review aims to carry out a situation analysis of the role that could be adopted by supplemental parenteral nutrition in attenuating alterations typical of end of life and potential improvement in quality of life.es_ES
dc.description.sponsorshipDpto Farmacia y Tecnología Farmacéuticaes_ES
dc.language.isoenges_ES
dc.publisherMDPIes_ES
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.titleA Narrative Review: Analysis of Supplemental Parenteral Nutrition in Adults at the End of Lifees_ES
dc.typejournal articlees_ES
dc.rights.accessRightsopen accesses_ES
dc.identifier.doi10.3390/ph17010065
dc.type.hasVersionVoRes_ES


Fichier(s) constituant ce document

[PDF]

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée

Attribution-NonCommercial-NoDerivatives 4.0 Internacional
Excepté là où spécifié autrement, la license de ce document est décrite en tant que Attribution-NonCommercial-NoDerivatives 4.0 Internacional